Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Quagliata
P2.04-14 Tumor Mutational Burden Assessed by a Targeted NGS Assay Predicts Benefit From Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
The Predictive Value of Tumor Mutation Burden for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer Is Affected by Patients’ Age
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Current Treatment Options in Oncology
Oncology
Pharmacology
Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)
Open Access Journal of Oncology and Medicine
Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
P2.04-13 the Immune Checkpoint, HVEM Contribute to Immune Escape in Non Small Cell Lung Cancer of Lacking PDL1 Expression
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.04-28 Use of Immune Checkpoint Inhibitors (ICIs) in Patients With Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Receiving Concurrent Metformin and Immune Checkpoint Inhibitors
Lung Cancer Management
Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients
Jurnal Respirasi